Time:
All Today Tomorrow This Week This Month

Introduction to immune checkpoints – the new hot target for cancer immunotherapy

Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry.

08-15-2017 XinPo Jiang, Ph.D. and Amy Mendenhall, Ph.D.

Learn More

Leveraging GenScript’s cytokines, antibodies, and protein purification tools to explore Ideas for your next grant

Wouldn't it be great if all the supplies you needed to obtain preliminary data for your next grant were available from the same vendor? This webinar will show you how to incorporate

06-28-2017 Amy Mendenhall, Ph.D.

Learn More

Characterization of the host antibody responses against anti-HIV/SIV antibodies delivered with AAV

Long-term delivery of neutralizing antibodies by means of recombinant adeno-associated virus (rAAV) is a novel and promising approach for the prevention

06-26-2017 Keshav

Learn More

Using High Throughput Antibody Screening Approaches to Accelerate Drug Discovery

Are you currently working on a Therapeutic Antibody project and looking for ways to accelerate your program? If yes, this webinar may be for you.

05-05-2017 Keshav Vasanthavada

Learn More

A Guide to CRISPR /Cas9 Delivery: How to Maximize Your Editing Efficiency

While CRISPR/Cas9 editing is utilized in a wide variety of cell types, editing efficiency continues to pose a challenge to researchers.

04-18-2017 Dr. Allison Mayle

Learn More

Integrated Antibody Drug Discovery: Lead Generation, Characterization and Optimization

Therapeutic antibody drugs show significant growth rate. Within oncology research alone, more than 20 therapeutic antibody drugs received FDA approval for new treatments or indications during 2015 and 2016. In addition, more than 300 therapeutic antibody

04-12-2017 Liusong Yin, Ph.D.

Learn More

< 27 28 29 30 31 32 33 34 35 36 > Total Pages 36